Gene Bio Systems
REL (Ab-503) Antibody - Cat. #: CSB-PA194896
REL (Ab-503) Antibody - Cat. #: CSB-PA194896
SKU:CSB-PA194896
Couldn't load pickup availability
Size :100ul
Clone Number:
Aliases:Avian reticuloendotheliosis antibody; C REL antibody; C Rel protein antibody; c Rel proto oncogene protein antibody; Oncogene REL antibody; Oncogene REL avian reticuloendotheliosis antibody; Proto-oncogene c-Rel antibody; REL antibody; REL_HUMAN antibody; v rel avian reticuloendotheliosis viral oncogene homolog antibody; v rel reticuloendotheliosis viral oncogene homolog antibody; V rel reticuloendotheliosis viral oncogene homolog (avian) antibody
Product Type:Polyclonal Antibody
Immunogen Species:Homo sapiens (Human)
UniProt ID:Q04864
Immunogen:Peptide sequence around aa.501~505 (T-S-S-D-S) derived from Human Rel.
Raised in:Rabbit
Species Reactivity:Human
Tested Applications:ELISA, IF; IF:1:100-1:200
Background:The REL gene encodes c-Rel, a transcription factor that is a member of the Rel/NFKB family, which also includes RELA (MIM 164014), RELB (604758), NFKB1 (MIM 164011), and NFKB2 (MIM 164012). These proteins are related through a highly conserved N-terminal region termed the 'Rel domain,' which is responsible for DNA binding, dimerization, nuclear localization, and binding to the NFKB inhibitor (MIM 164008) (Belguise and Sonenshein, 2007 (PubMed18037997)).
Copley RR et al. (2007) Genome Res. 17(9):1327-35.
Liu YW,et al.(2007) Cell Mol Life Sci. 64(24):3282-94.
Banerjee D, (2005) Immunity. 23(4):445-58.
Clonality:Polyclonal
Isotype:IgG
Purification Method:Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide.
Conjugate:Non-conjugated
Buffer:Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Form:liquid
Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Names:REL
Research Areas:Epigenetics and Nuclear Signaling;Cancer;Signal transduction
